RDX-002, a novel iMTP inhibitor, showed promising results in a Ph2 study, reducing blood fat and weight regain after GLP-1 ...

Taking weight off with a glucagon-like peptide-1 (GLP-1) receptor agonist and keeping it off once the drug has been discontinued has been a tall order but Response Pharmaceuticals Inc. is seeing ...

Results from a Phase II trial (NCT06640972) showed that patients treated with RDX-002 experienced significant reductions in ...

US biotech Response Pharmaceuticals (Nasdaq: RSPN) has unveiled top-line Phase II results for its experimental obesity ...

Response is also considering running trials of the weight management drug RDX-002 in combination with GLP-1RA therapies.

Response Pharmaceuticals has shared phase 2 data in post-GLP-1 patients, linking its ex-Sanofi asset to reductions in ...

Among the prominent players are Intrabio Inc., Niagen Bioscience Inc., and Quince Therapeutics Inc. Typically, A-T is first diagnosed before the age of 5 as children begin to develop an altered gait.

Shop 2022 Acura RDX vehicles for sale at Cars.com. Research, compare, and save listings, or contact sellers directly from 353 2022 RDX models nationwide.

Get the latest in-depth reviews, ratings, pricing and more for the 2013 Acura RDX from Consumer Reports.